Skip to main content
SPRY logo

SPRY · ARS Pharmaceuticals, Inc. · Analyst Estimates

Track SPRY — free
$3.11 -0.25 (-7.44%) Play latest call Q3 2026 earnings call transcript
Market Cap
$337.78M
Shares
100.53M
Volume · Nov 20 1.02M Avg daily vol (3M) 1.81M

Analyst Estimates

Compare analyst forecasts for ARS Pharmaceuticals, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-17 06:28 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.98
-1.91
-1.85
3
-1.88
-1.87
-1.84
-1.72
1
1
0
0
Revenue
USD
Publication date not stated
116.33M
120.44M
125.10M
4
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.89
-0.82
-0.71
3
-0.90
-0.90
-0.89
-0.94
1
1
0
0
Revenue
USD
Publication date not stated
142.06M
165.44M
189.80M
4
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.39
-0.31
-0.26
3
-0.26
-0.31
-0.30
-0.34
1
1
0
0
Revenue
USD
Publication date not stated
22.28M
26.47M
31.10M
4
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.36
-0.32
-0.27
2
-0.39
-0.39
-0.39
-0.25
1
1
0
0
Revenue
USD
Publication date not stated
24.50M
25.19M
26.50M
3
— — — — — — — —
Key facts CIK 1671858 CUSIP 82835W108 13F (30d) 206 filings 181 filers Visit website Investor relations